·2,447,543篇论文数据，部分数据来源于NoteExpress
These long roads have led to good endings before: Myogen was flat for the first eight years or so before skyrocketing in the public markets on good clinical data to an acquisition by Gilead at least 10x above its venture round prices.
FORBES: AVEO: An early stage VC's perspective
应用推荐
模块上移
模块下移
不移动